Author

Noa Lavi

OpenAlex ID: A5137344364

Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis

2026 · Efstathios Kastritis, Giovanni Palladini, et al. · Blood · 4

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials

2026 · Ashutosh D. Wechalekar, Angela Dispenzieri, et al. · Journal of Clinical Oncology · 2

Works count: 2

Citation count: 6

H-index: 2

I10-index: